Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome.
Saved in:
| Title: | Repurposing Approved Drugs as Inhibitors of K |
|---|---|
| Authors: | Ekins S; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA. sean@collaborationspharma.com., Gerlach J; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA., Zorn KM; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA., Antonio BM; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA., Lin Z; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA., Gerlach A; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA. |
| Source: | Pharmaceutical research [Pharm Res] 2019 Jul 22; Vol. 36 (9), pp. 137. Date of Electronic Publication: 2019 Jul 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-904X |
|---|---|
| DOI: | 10.1007/s11095-019-2671-y |
